CAMBRIDGE, Mass., April 24, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management will host a conference call on Tuesday, May 1, 2007 at 8:30 a.m. EDT. In the conference call, management will provide a business update, including implications of the proposed acquisition of MedImmune, Inc. (Nasdaq:MEDI) by AstraZeneca PLC (NYSE:AZN) for the companies' collaboration. Management will also discuss results for the quarter ended March 31, 2007
To participate in the conference call, please dial 800-289-0528 (domestic) and 1-913-981-5522 (international) five minutes prior to the start time. A live webcast of the conference call can be accessed in the Investor section of Infinity's website at www.ipi.com. An archived version of the webcast will be available on Infinity's website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com.
INFI-G